نتایج جستجو برای: anti graft agencies

تعداد نتایج: 470520  

2014
Jorge Malheiro Sandra Tafulo Leonídio Dias La Salete Martins Isabel Fonseca Manuela Almeida Sofia Pedroso Fátima Freitas Idalina Beirão António Castro Henriques António Cabrita

INTRODUCTION Posttransplantation allosensitization prevalence and effect on kidney grafts outcomes remain unsettled. METHODS Between 2007 and 2012, 408 patients received a primary kidney graft (with 68 patients also receiving a pancreas graft) after a negative cytotoxic crossmatch. All patients had a pretransplant negative anti-HLA screening and 0% panel reactive antibodies. We analyzed retro...

Journal: :Journal of the American Society of Nephrology : JASN 1999
J M Sorof E K Sullivan A Tejani R J Portman

Hypertension after renal transplantation occurs commonly and, in adults, is associated with decreased graft survival. The North American Pediatric Renal Transplant Cooperative Study database was analyzed to determine: (1) the percent use of antihypertensive (anti-HTN) medication based on donor type, race, age, and acute rejection status; and (2) whether use of anti-HTN medication is associated ...

Journal: :International Journal of Innovative Research and Development 2018

Journal: :Blood 2011
Stefan O Ciurea Peter F Thall Xuemei Wang Sa A Wang Ying Hu Pedro Cano Fleur Aung Gabriela Rondon Jeffrey J Molldrem Martin Korbling Elizabeth J Shpall Marcos de Lima Richard E Champlin Marcelo Fernandez-Vina

Anti-HLA donor-specific Abs (DSAs) have been reported to be associated with graft failure in mismatched hematopoietic stem cell transplantation; however, their role in the development of graft failure in matched unrelated donor (MUD) transplantation remains unclear. We hypothesize that DSAs against a mismatched HLA-DPB1 locus is associated with graft failure in this setting. The presence of ant...

1998
Thomas G. Markees Nancy E. Phillips Ethel J. Gordon Randolph J. Noelle Leonard D. Shultz John P. Mordes Dale L. Greiner Aldo A. Rossini

Treatment of C57BL/6 mice with one transfusion of BALB/c spleen cells and anti-CD154 (anti–CD40-ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for z 50 d without further intervention. The protocol induces long-term allograft survival, but the mechanism is unknown. We now report: ( a ) addition of thymectomy to the protocol permitted skin a...

Journal: :The Journal of clinical investigation 1998
T G Markees N E Phillips E J Gordon R J Noelle L D Shultz J P Mordes D L Greiner A A Rossini

Treatment of C57BL/6 mice with one transfusion of BALB/c spleen cells and anti-CD154 (anti-CD40-ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for approximately 50 d without further intervention. The protocol induces long-term allograft survival, but the mechanism is unknown. We now report: (a) addition of thymectomy to the protocol permit...

1998
Thomas G. Markees Nancy E. Phillips Ethel J. Gordon Randolph J. Noelle Leonard D. Shultz John P. Mordes Dale L. Greiner Aldo A. Rossini

Treatment of C57BL/6 mice with one transfusion of BALB/c spleen cells and anti-CD154 (anti–CD40-ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for z 50 d without further intervention. The protocol induces long-term allograft survival, but the mechanism is unknown. We now report: ( a ) addition of thymectomy to the protocol permitted skin a...

Journal: :Haematologica 2017
Annalisa Ruggeri Yuqian Sun Myriam Labopin Andrea Bacigalupo Francesca Lorentino William Arcese Stella Santarone Zafer Gülbas Didier Blaise Giuseppe Messina Ardeshi Ghavamzadeh Florent Malard Benedetto Bruno Jose Luis Diez-Martin Yener Koc Fabio Ciceri Mohamad Mohty Arnon Nagler

Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical stem cell transplantation. There is no consensus on the optimal graft-versus-host disease prophylaxis. This study compared the two most commonly used graft-versus-host disease prophylaxis regimens (post-transplant cyclophosphamide-based vs. the anti-thymocyte globulin-based) in adults with acute myeloid l...

2006
Jeong-hoon Lee Jongwon Ha Shi-hwa Kim Sang Joon Kim

To facilitate the establishment of mixed chimerism with limited dose of bone marrow (BM) cells, and to achieve tolerance in skin graft model, combined blocking of costimulatory pathway and IL-2 pathway was used in minimally myeloablative model using busulfan. BM cells (2.5x10(7)) of BALB/c were injected into C57BL/6 mice at day 0 with full thickness skin graft after single dose injection of bus...

Journal: :Transplantation proceedings 2010
E Silva A Alba A Castro M Carrascal E Buckel J Aguiló C Herzog L Calabrán J Morales J A Fierro

BACKGROUND HLA Matchmaker is a computer algorithm developed to evaluate donor/receptor compatibility comparing sequences of polymorphic aminoacids (eplets) present in human leukocyte antigen (HLA) molecules. The aim of this study was to evaluate the predictive value of HLA Matchmaker for patient and graft survival, graft survival free of rejection, and the presence of anti HLA antibodies. MET...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید